Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board
Go back to Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board| (AMEX: DTCFF) | Delayed: 0.39 +0.02 (5.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.37 | 52 Week High | $ | |||
| Open | $0.36 | 52 Week Low | $ | |||
| Day High | $0.39 | P/E | N/A | |||
| Day Low | $0.36 | EPS | $ | |||
| Volume | 4,227 | |||||

